Form Ds provide information on individual, unregistered securities offerings.
Search by Recipient Name or Primary Issuer:
| Recipient | CRD | Primary Issuer | CIK | Filing Date | Form Type | Total Offering Amount | Total Amount Sold |
|---|---|---|---|---|---|---|---|
| CANTOR FITZGERALD & CO. | 134 | CF Texas Multifamily Portfolio DST | 1885921 | 11/16/2022 | D/A | $94,811,000 | $94,811,000 |
| CANTOR FITZGERALD & CO. | 134 | CF Glenmuir Multifamily DST | 1872937 | 11/28/2022 | D/A | $86,100,000 | $86,100,000 |
| CANTOR FITZGERALD & CO. | 134 | CF Glenmuir Multifamily DST | 1872937 | 10/25/2021 | D/A | $86,100,000 | $80,372,825 |
| CANTOR FITZGERALD & CO. | 134 | SELECTA BIOSCIENCES INC | 1453687 | 01/02/2020 | D | $70,000,000 | $70,000,000 |
| CANTOR FITZGERALD & CO. | 134 | CF ON3 Lifesciences Parent DST | 1928276 | 02/28/2023 | D/A | $69,800,000 | $69,800,000 |
| CANTOR FITZGERALD & CO. | 134 | CF Glenmuir Multifamily DST | 1872937 | 09/27/2021 | D | $86,100,000 | $67,664,789 |
| CANTOR FITZGERALD & CO. | 134 | CF Texas Multifamily Portfolio DST | 1885921 | 11/01/2021 | D/A | $94,811,000 | $66,449,557 |
| CANTOR FITZGERALD & CO. | 134 | X4 Pharmaceuticals, Inc | 1501697 | 06/01/2023 | D | $65,023,725 | $65,015,462 |
| CANTOR FITZGERALD & CO. | 134 | CF Livonia DST | 1778537 | 01/13/2020 | D/A | $61,900,000 | $61,900,000 |
| CANTOR FITZGERALD & CO. | 134 | CF ARRABELLA MULTIFAMILY DST | 1935650 | 02/07/2023 | D/A | $58,492,000 | $58,492,000 |